333D Limited (T3D) AI Stock Analysis

• Market Cap: AU$6.34M
• Dividend Yield: N/A
• Average Volume (3M): 1.82M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.26
• Revenue Growth: 426.44%
• EPS Growth: N/A
• Country: AU
• Employees: N/A
• Sector: Technology
• Sector Strength: 88
• Industry: Computer Hardware
• EPS (TTM): >-0.01
• Shares Outstanding: 211,395,480
• 10 Day Avg. Volume: 946,403
• 30 Day Avg. Volume: 1,817,650
• PEG Ratio: -0.06
• Price to Book (P/B): -21.32
• Price to Sales (P/S): 0.95
• P/FCF Ratio: 13.56
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: AU$0.02 ▼(-20.00% Downside)
• Action: Reiterated Date: 02/10/26
• Date: Action: Reiterated 02/10/26

The score is held down primarily by balance-sheet fragility (negative equity) and a history of volatile earnings/cash flow despite a strong FY2025 rebound. Technicals add further pressure with a weak trend and bearish momentum. Valuation is also demanding (high P/E), limiting upside unless the turnaround proves durable.

Positive Factors

Revenue & Profit Rebound

The FY2025 rebound — ~60% revenue growth and a return to ~14% net margin — suggests the company can regain scalable sales and improve unit economics. If structural (not one-off), this supports sustainable operating leverage, better cash conversion and a firmer base for multi-quarter recovery.

Low Financial Leverage

Zero reported debt across FY2022–FY2025 materially reduces solvency and interest burdens, giving management flexibility to invest in growth or withstand downturns. Low leverage is a durable buffer versus peers and lowers risk of debt-driven distress during uneven cash cycles.

Improving Cash Generation

Positive operating and free cash flow in FY2025 indicates the business can begin self-funding operations and reduces immediate external financing needs. If the improvement persists, it supports reinvestment, working capital management and a lower probability of dilutive capital raises.

Negative Factors

Negative Shareholders' Equity

Negative equity reflects accumulated losses and a thin capital base, limiting the company's ability to absorb shocks or fund growth internally. Structurally, this elevates refinancing and recapitalization risk, making future financing more dilutive or costly if performance weakens.

Historic Earnings Volatility

A multi-year pattern of losses and large margin swings undermines predictability of earnings and planning. Persistent volatility erodes stakeholder confidence, complicates long-term contracts or hiring, and means the FY2025 recovery may be fragile unless underlying business model issues are resolved.

Inconsistent Cash Flow History

Irregular cash flows and prior sizable outflows show cash generation is not yet stable. This inconsistency increases reliance on external funding during down cycles, magnifies the impact of negative equity, and raises the risk that short-term improvements will not translate into sustained self-financing.

333D Limited Business Overview & Revenue Model

Company Description

333D Limited, together with its subsidiaries, provides 3D printing services in Australia. The company offers 3D printing equipment and consumables; and sells 3D prints. 333D Limited was incorporated in 2006 and is based in Laverton North, Australia.

How the Company Makes Money

null

333D Limited Financial Statement Overview

Summary

FY2025 shows a strong rebound (revenue up ~60%, return to positive net profit with ~14% margin, and positive operating/free cash flow). However, multi-year profitability and cash-flow volatility plus negative shareholders’ equity in FY2025 materially elevate risk and reduce confidence in durability.

Income Statement

The latest annual period (FY2025) shows a sharp rebound with revenue up ~60% and a return to positive net profit (~14% margin), supported by a healthier gross margin (~40%). However, profitability has been highly volatile: FY2020–FY2024 featured persistent losses and, in several years, deeply negative margins, which raises questions around earnings durability and the consistency of the underlying business model.

Balance Sheet

Leverage is currently low (total debt reported at zero in FY2022–FY2025), which reduces financial risk. The key weakness is solvency: shareholders’ equity is negative in FY2025 (and was materially negative across several prior years), implying accumulated losses and a thin capital base. Total assets increased in FY2025, but negative equity limits balance-sheet flexibility and can increase refinancing/raising-capital risk if performance weakens.

Cash Flow

Cash generation improved in FY2025 with positive operating and free cash flow (~$70.7k), a meaningful step up from cash burn in FY2022–FY2024. That said, cash flow has been inconsistent year-to-year (including sizable outflows in FY2023 and FY2022), and FY2025 free cash flow declined versus the prior period on the provided growth metric. Overall, cash flow is improving but not yet stable enough to be viewed as structurally strong.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Income Statement
Total Revenue	1.11M	1.01M	190.31K	23.95K	63.68K	114.97K
Gross Profit	540.53K	403.08K	181.29K	-146.37K	-209.88K	-24.78K
EBITDA	-182.13K	144.81K	-600.60K	-836.10K	-1.22M	-488.88K
Net Income	8.97K	143.78K	-506.61K	-724.97K	-1.24M	-338.79K
Balance Sheet
Total Assets	1.12M	641.11K	24.68K	89.29K	441.52K	132.40K
Cash, Cash Equivalents and Short-Term Investments	736.33K	75.27K	4.58K	65.05K	415.73K	99.21K
Total Debt	0.00	0.00	0.00	0.00	0.00	300.00K
Total Liabilities	385.73K	686.08K	553.85K	505.88K	365.68K	678.88K
Stockholders Equity	735.03K	-44.96K	-529.17K	-416.60K	75.84K	-546.47K
Cash Flow
Free Cash Flow	424.93K	70.68K	-60.46K	-350.69K	-195.78K	90.04K
Operating Cash Flow	424.93K	70.68K	-60.46K	-350.69K	-195.78K	90.04K
Investing Cash Flow	-370.50K	0.00	0.00	0.00	0.00	0.00
Financing Cash Flow	629.57K	0.00	0.00	0.00	512.30K	0.00

333D Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
CT1	61 Neutral	AU$2.95M	10.32	1.10%	―	34.27%	―
T3D	42 Neutral	AU$6.34M	-6.33	2.60%	―	426.44%	―
1TT	37 Underperform	AU$1.43M	-0.06	-562.56%	―	―	―

333D Limited Corporate Events

333D Limited Issues Shares to Consultant for IT Development Services

333D Limited has applied for quotation on the ASX of 9,875,000 new fully paid ordinary shares, to be issued on 13 March 2026 under the code T3D. The shares are being issued as part remuneration to a consultant for IT development and commercialisation services, indicating the company is using equity-based compensation to advance its technology initiatives while conserving cash resources.

This issuance modestly increases the company’s share base and aligns consultant incentives with shareholder interests, potentially supporting progress on key development and commercialisation projects. For investors, the move signals continued investment in IT capabilities and the use of strategic share-based payments to fund operational and growth-related services.

The most recent analyst rating on (AU:T3D) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D Lifts Revenue and NTA but Posts Wider Annual Loss

333D Limited reported revenue from ordinary activities of $588,678 for the year ended 31 December 2025, a 23% increase on the prior year, indicating improving top-line performance in its operations. However, the company recorded a net loss attributable to members of $282,030, down 92% compared with the previous year’s result, and the directors again decided not to declare a dividend for the period.

Despite the loss, 333D’s net tangible assets per share improved materially to 0.365 cents from a negative 0.029 cents a year earlier, signalling a stronger balance sheet position for shareholders. The interim financial report for the half-year ended 31 December 2025 was reviewed without any material uncertainty regarding going concern, providing some reassurance to investors about the company’s financial stability and ongoing operations.

The most recent analyst rating on (AU:T3D) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D Flags Material Impairment in Bitcoin Treasury Holdings

333D Limited has reported that the market value of its Bitcoin treasury holdings stood at $228,838 as at 1 February 2026, representing an impairment of $141,661, or 13.6% of the consolidated group’s total assets, thereby triggering its continuous disclosure obligations under ASX Listing Rule 3.1. The company attributed the decline in the Australian dollar value of its Bitcoin position to a combination of cryptocurrency price volatility and a strengthening Australian dollar against the US dollar, and noted that it does not currently hedge its cryptocurrency or foreign exchange exposures, meaning investors should expect ongoing variability in reported valuations as part of its broader digital asset treasury strategy.

The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D posts sixth straight quarter of revenue growth and advances blockchain healthcare push

333D Limited reported its sixth consecutive quarter of growth in cash receipts, generating $330,917 from digital asset management contracts in the December quarter, reflecting a 3.92% increase and underscoring the success of its strategic pivot into healthcare-focused digital asset management. The company recorded net operating cash outflows of $99,180 on quarterly expenditure of about $430,097, ended the period with combined cash and Bitcoin holdings of $993,691, and highlighted progress in its BioScan 360 collaboration, having successfully stored full body MRI scan data on the blockchain with plans to scale this decentralised, patient-controlled data solution across the preventative healthcare market.

The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.